Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients
Clinical trial NCT06427031 · COMPLETED
Trial details
- NCT number
- NCT06427031
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2024-05-22
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.